August 7th 2025
Youth with neurodevelopmental disorders face significant suicide risks.
New research reveals that discontinuing long-term benzodiazepine therapy may increase risks of mortality and other adverse outcomes, challenging common assumptions.
Read More
Specter of Suicidality with Antiobesity Med Looms Despite Disparate Study Findings
September 24th 2024Reports of suicidality with GLP-1RA antiobesity medication are supported by analysis of WHO data, but no association is found in large population cohort study or analysis of clinical trials.
Read More